In November 2021, which of the following countries has approved a COVID-19 antiviral pill Molnupiravir, jointly developed by United States-based Merck and Ridgeback Biotherapeutics?
In November 2021, which of the following countries has approved a COVID-19 antiviral pill Molnupiravir, jointly developed by United States-based Merck and Ridgeback Biotherapeutics? Correct Answer Britain
The correct answer is Britain.
Key Points
- Britain has become the first country in the world to approve a COVID-19 antiviral pill jointly developed by United States-based Merck and Ridgeback Biotherapeutics.
- Britain's Medicines and Healthcare products Regulatory Agency (MHRA) recommended the drug, molnupiravir, be used as soon as possible following a positive COVID-19 test and within five days of the onset of symptoms.
Important Points
- This is the first oral antiviral treatment for COVID-19 to get approved, with the green light coming ahead of potential United States regulatory clearance.
- The drug, to be branded Lagevrio in Britain, is designed to introduce errors into the genetic code of the virus that causes COVID-19 and is taken twice a day for five days.
Additional Information
- In November 2021, World Health Organisation has recommended the Emergency Use Listing status for Bharat Biotech’s Covaxin.
- Covaxin is a whole virion-inactivated vaccine against SARS-CoV2, developed in partnership with ICMR (Indian Council of Medical Research) and NIV (National Institute of Virology), Pune.
মোঃ আরিফুল ইসলাম
Feb 20, 2025